Todd A Fehniger MD/PhD
Todd A Fehniger MD/PhD
Professor of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis
Dirección de correo verificada de - Página principal
Citado por
Citado por
The biology of human natural killer-cell subsets
MA Cooper, TA Fehniger, MA Caligiuri
Trends in immunology 22 (11), 633-640, 2001
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
MA Cooper, TA Fehniger, SC Turner, KS Chen, BA Ghaheri, T Ghayur, ...
Blood, The Journal of the American Society of Hematology 97 (10), 3146-3151, 2001
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
Interleukin 15: biology and relevance to human disease
TA Fehniger, MA Caligiuri
Blood, The Journal of the American Society of Hematology 97 (1), 14-32, 2001
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
X Cao, SF Cai, TA Fehniger, J Song, LI Collins, DR Piwnica-Worms, ...
Immunity 27 (4), 635-646, 2007
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell–derived IL-2: a potential new link between adaptive and innate immunity
TA Fehniger, MA Cooper, GJ Nuovo, M Cella, F Facchetti, M Colonna, ...
Blood, The Journal of the American Society of Hematology 101 (8), 3052-3057, 2003
Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune …
TA Fehniger, MH Shah, MJ Turner, JB VanDeusen, SP Whitman, ...
The Journal of Immunology 162 (8), 4511-4520, 1999
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
SS Farag, TA Fehniger, L Ruggeri, A Velardi, MA Caligiuri
Blood, The Journal of the American Society of Hematology 100 (6), 1935-1947, 2002
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ...
New England Journal of Medicine 375 (21), 2023-2036, 2016
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
R Romee, M Rosario, MM Berrien-Elliott, JA Wagner, BA Jewell, ...
Science translational medicine 8 (357), 357ra123-357ra123, 2016
NK cell and DC interactions
MA Cooper, TA Fehniger, A Fuchs, M Colonna, MA Caligiuri
Trends in immunology 25 (1), 47-52, 2004
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells
MA Cooper, JE Bush, TA Fehniger, JB VanDeusen, RE Waite, Y Liu, ...
Blood, The Journal of the American Society of Hematology 100 (10), 3633-3638, 2002
Cytokine activation induces human memory-like NK cells
R Romee, SE Schneider, JW Leong, JM Chase, CR Keppel, RP Sullivan, ...
Blood, The Journal of the American Society of Hematology 120 (24), 4751-4760, 2012
A potential role for interleukin-15 in the regulation of human natural killer cell survival.
WE Carson, TA Fehniger, S Haldar, K Eckhert, MJ Lindemann, CF Lai, ...
The Journal of clinical investigation 99 (5), 937-943, 1997
Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs
TA Fehniger, SF Cai, X Cao, AJ Bredemeyer, RM Presti, AR French, ...
Immunity 26 (6), 798-811, 2007
Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype Cd8+ T Cells
TA Fehniger, K Suzuki, A Ponnappan, JB VanDeusen, MA Cooper, ...
The Journal of experimental medicine 193 (2), 219-232, 2001
Interleukin-2 and interleukin-15: immunotherapy for cancer
TA Fehniger, MA Cooper, MA Caligiuri
Cytokine & growth factor reviews 13 (2), 169-183, 2002
Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets
M Frey, NB Packianathan, TA Fehniger, ME Ross, WC Wang, CC Stewart, ...
The Journal of Immunology 161 (1), 400-408, 1998
Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15
H Yu, TA Fehniger, P Fuchshuber, KS Thiel, E Vivier, WE Carson, ...
Blood, The Journal of the American Society of Hematology 92 (10), 3647-3657, 1998
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
R Romee, S Cooley, MM Berrien-Elliott, P Westervelt, MR Verneris, ...
Blood, The Journal of the American Society of Hematology 131 (23), 2515-2527, 2018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20